Boxer Capital

Boxer Capital accounts for 21 tracked companies with verified cap-table data, 21 of which disclose round sizes totalling $5.1B. The median disclosed raise is $205M, and the largest is Point Biopharma at $650M, ahead of Mirador Therapeutics ($650M) and Spyre Therapeutics ($644M).

The names that recur most often on these portfolio cap tables are Boxer Capital (21 companies), RA Capital Management (8 companies), Invus (6 companies), Janus Henderson Investors (6 companies), Logos Capital (5 companies), Nextech Invest (5 companies). By latest disclosed round, the market skews Series C (8), Series B (4), Series D (3), Series A (3).

• Companies tracked: 21
• Disclosed funding total: $5.1B across 21 companies
• Median disclosed raise: $205M
• Largest raise: Point Biopharma — $650M
• Stage mix: Series C 8 · Series B 4 · Series D 3 · Series A 3
• Most recent dated round: 2026-06-30

Best funded Boxer Capital companies

1. Point Biopharma — $650M (latest: IPO)
2. Mirador Therapeutics — $650M (latest: Series B)
3. Spyre Therapeutics — $644M (latest: Growth)
4. Flare Therapeutics — $287M (latest: Series C)
5. Encoded Therapeutics — $240M (latest: Series D)
6. Alterome Therapeutics — $231M (latest: Series A)
7. Enliven Therapeutics — $230M (latest: Growth)
8. Semisic — $222M (latest: Series B)
9. Asher Bio — $215M (latest: Series C)
10. Silverback Therapeutics — $210M (latest: Series C)
11. ITeos Therapeutics — $205M (latest: Series B)
12. Connect Biopharmaceuticals — $195M (latest: Series C)
13. Kinnate Biopharma — $195M (latest: Series C)
14. Black Diamond Therapeutics — $194M (latest: Series C)
15. Shoreline Biosciences — $183M (latest: Series B)

Boxer Capital — related firms and companies (56)

• Point Biopharma
• Mirador Therapeutics
• Spyre Therapeutics
• Flare Therapeutics
• Encoded Therapeutics
• Alterome Therapeutics
• Enliven Therapeutics
• Semisic
• Boxer Capital co-investors 2026
• Kinnate Biopharma
• Investors like International Finance Corporation
• Investors like Emergence Capital
• Investors like Recursive Ventures
• Investors like Casdin Capital
• BioAtla
• ITeos Therapeutics
• Investors like Kleiner Perkins
• Investors like Liquid 2 Ventures
• Investors like Floodgate
• Investors like Great Oaks Venture Capital
• Mersana Therapeutics
• Asher Bio
• Investors like GSR Ventures
• Investors like Ridge Ventures
• Investors like Accel
• Investors like Menlo Ventures
• Ajax Therapeutics
• Investors like Lightspeed Venture Partners
• Investors like Initialized Capital
• Investors like Maveron
• Investors like Thrive Capital
• Investors like Boxer Capital
• Black Diamond Therapeutics
• Investors like Peak XV Partners
• Investors like Sofinnova Investments
• Investors like General Catalyst
• Investors like Bain Capital Ventures
• Lusaris Therapeutics
• Connect Biopharmaceuticals
• Investors like Upfront Ventures
• Investors like AME Cloud Ventures
• Investors like Fika Ventures
• Investors like Irving Investors
• Ceptur Therapeutics
• Silverback Therapeutics
• Investors like Trinity Ventures
• Investors like Khosla Ventures
• Investors like 500 Global
• Investors like IVP
• Vivace Therapeutics
• Investors like SOSV
• Investors like Eniac Ventures
• Investors like Storm Ventures
• Investors like Maven Ventures
• Companies backed by Boxer Capital
• Shoreline Biosciences

Boxer Capital alternatives · All research reports